EH301 for ALS
Working in collaboration with the Spanish Foundation for ALS Research (FUNDELA), the results of this pilot study showed evidence the experimental therapeutic EH301 can be used in treatment of amyotrophic lateral sclerosis (ALS). Publication here. ClinicalTrials.gov Identifier: NCT03489200